Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region

Journal of Neuro-Oncology

Volumn 81, Issue 2, 2007, Pages 131-137

  Korshunov, Andrey ^a   Cherekaev, Vasiliy ^a   Bekyashev, Ali ^a   Sycheva, Regina ^a  

^a BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

Author keywords

Cytogenetics; Invasion; Meningioma; Microarrays; Skull base

Indexed keywords

ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BRAIN REGION; BRAIN SURGERY; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 1P; CHROMOSOME 20; CHROMOSOME 22Q; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG RESEARCH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENCE RISK; SPHENOID; TUMOR GROWTH;

ADULT; AGED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID HYBRIDIZATION; SPHENOID BONE;

EID: 33845704577     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9214-1     Document Type: Article

References (36)

1. Louis DN, Scheithauer BW, Budka H et al (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Tumours of the nervous system. Pathology and genetics: World Health Organization international classification of tumors. IARC Press, Lyon, pp 176-184
2. Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286
3. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202
4. Pieper DR, Al Mefty O, Hanada Y et al (1999) Hyperostosis associated with meningioma of the cranial base: Secondary changes or tumour invasion. Neurosurgery 44:742-746
5. Roser F, Nakamura M, Jacobs C et al (2005) Sphenoid wing meningioma with osseous involvement. Surg Neurol 64:37-43
6. Shrivastava RK, Sen C, Constantion PD et al (2005) Sphenoorbital meningiomas: Surgical limitations and lessons learned in their long-term management. J Neurosurg 03:491-497
7. Weber RG, Bostrom J, Wolter M et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724
8. Snidjers AM, Pinkel D, Albertson DG (2003) Current status and future prospects of array-based comparative genomic hybridization. Brief Funct Genomic Proteomic 2:37-45
9. Korshunov A, Shishkina L, Golanov A (2002) DNA topoisomerase II alpha and cyclin A immunoexpression in meningiomas and its prognostic significance. An analysis of 263 cases. Arch Pathol Lab Med 126:1079-1086
10. Korshunov A, Sycheva R, Golanov A (2006) Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization. Acta Neuropathol 111:465-474
11. Nakahara Y, Shiraishi T, Okamoto H et al (2004) Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization. Neuro-Oncol 6:281-289
12. Sasaki T, Arai H, Beppu T et al (2003) Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300). Brain Tumor Pathol 20:59-63
13. Suzuki T, Maruno M, Wada K et al (2004) Genetic analysis of human glioblastoma using a genomic microarray system. Brain Tumor Pathol 21:27-34
14. Wada K, Maruno M, Suzuki T et al (2004) Chromosomal and genetic aberrations differ with meningioma subtype. Brain Tumor Pathol 21:127-133
15. Wada K, Maruno M, Suzuki T et al (2005) Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray. Neurol Res 27:747-754
16. Buschges R, Ichimura K, Weber RG et al (2002) Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas. Brain Pathol 12:145-153
17. Cai DX, James CD, Scheithauer BW et al (2001) PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol 115:213-218
18. Ketter R, Henn W, Niedermayer I et al (2001) Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: A retrospective study of 198 cases. J Neurosurg 95:601-607
19. Lamszus K, Kluwe L, Matschke J et al (1999) Allelic losses at 1p, 9q, 10q, 14q and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110:103-110
20. Lee JY, Finkelstein S, Hamilton RL et al (2004) Loss of heterozygosity analysis of bening, atypical and anaplastic meningiomas. Neurosurgery 55:1163-1173
21. Leraud P, Dezamis E, Aguirre-Cruz L et al (2004) Prognostic value of allelic losses and telomerase activity in meningiomas. J Neurosurg 100:303-309
22. Ozaki S, Nishizaki T, Ito H et al (1999) Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningiomas. J Neurooncol 41:167-174
23. Bello MJ, de Campos JM, Vaquero J et al (2001) High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 120:30-36
24. Lomas J, Bello MJ, Arjona D et al (2001) Analysis of p73 gene in meningiomas with deletion 1p. Cancer Genet Cytogenet 129:88-91
25. Nozaki M, Tada M, Kashiwazaki H et al (2001) p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade. Brain Pathol 11:296-305
26. Piaskowski S, Rieske P, Szybka M et al (2005) GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet 162:63-67
27. Buckley PG, Jarbo K, Menzel U et al (2005) Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Cancer Res 65:2653-2661
28. Cai DX, Banerjee R, Scheithauer BW et al (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningiomas. J Neuropathol Exp Neurol 61:628-636
29. Maillo A, Orfao A, Sayagues GM et al (2003) New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. J Clin Oncol 21:3285-3295
30. Tabernero MD, Espinosa AB, Maillo A et al (2005) Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: Correlation with clinical, pathological, and prognostic features. Am J Clin Pathol 123:744-751
31. Lusis EA, Watson MA, Chicoine MR et al (2005) Integrative genome analysis identified NDGR2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningiomas. Cancer Res 65:7121-7126
32. Hase T, Kawashiri S, Tanaka A et al (2006) Correlation of basic fibroblast growth factor expression with the invasion and prognosis of oral squamous cell carcinomas. J Oral Pathol Med 35:136-139
33. Albrecht B, Hausmann M, Zitzelsberger H et al (2004) Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarnoma. J Pathol 203: 780-788
34. Katoh M (2005) WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14:1583-1588
35. Ntayi C, Labrousse AL, Debert R et al (2004) Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol 122:256-265
36. Asgharian B, Chen YJ, Patronas NJ et al (2004) Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 10:869-880